Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Atea Pharmaceuticals GAAP EPS of -$0.43 beats by $0.07

May 08, 2023 4:13 PM ETAtea Pharmaceuticals, Inc. (AVIR)By: Mary Christine Joy, SA News Editor
  • Atea Pharmaceuticals press release (NASDAQ:AVIR): Q1 GAAP EPS of -$0.43 beats by $0.07.
  • Cash, Cash Equivalents and Marketable Securities: $620.5 million at March 31, 2023 compared to $646.7 million at December 31, 2022.

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

More Trending News

See More »

About AVIR

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AVIR--
Atea Pharmaceuticals, Inc.
XERS--
Xeris Biopharma Holdings, Inc.
NUVB--
Nuvation Bio Inc.
TERN--
Terns Pharmaceuticals, Inc.
EYPT--
EyePoint Pharmaceuticals, Inc.
Compare

Trending Analysis

Trending News

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.